Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of leucovorin (Zuoyue) rescue in high-dose methotrexate therapy for pediatric acute lymphoblastic leukemia
ChiCTR2500096355Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of folinic acid in acute lymphoblastic leukemia (ALL), sponsored by Beijing Children's Hospital. Primary endpoint: Adverse reactions. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
folinic acid
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR2500096355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096355.